Advertisement
Screener

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Shareholders' Equity

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Shareholders' Equity

XYNOMIC PHARMACEUTICALS HOLDINGS, INC. had Shareholders' Equity of -$22.56 million as of 2019-12-31, per its 10-K filed 2020-06-01.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2020-06-01

  • 2019-12-31: Stockholders' Equity Attributable to Parent -$22.56M.
  • 2019-09-30: Stockholders' Equity Attributable to Parent -$19.85M.
  • 2019-06-30: Stockholders' Equity Attributable to Parent -$15.04M.
  • 2019-03-31: Stockholders' Equity Attributable to Parent -$28.29M; Stockholders' Equity Attributable to Parent as first filed $5.00M.
Period endStockholders' Equity Attributable to ParentStockholders' Equity Attributable to Parent as first filed
2019-12-31-$22.56M
10-K · filed 2020-06-01
2019-09-30-$19.85M
10-Q · filed 2019-11-14
2019-06-30-$15.04M
10-Q · filed 2019-11-14
2019-03-31-$28.29M
10-Q · filed 2019-08-15
$5.00M
10-Q · filed 2019-05-14
2018-12-31-$20.09M
10-K · filed 2020-06-01
$5.00M
10-K · filed 2019-03-05
2018-09-30$2.47M
10-Q · filed 2019-11-14
$5.00M
10-Q · filed 2018-11-13
2018-06-30-$11.26M
10-Q · filed 2019-11-14
$5.00M
10-Q · filed 2018-08-07
2018-03-31$5.00M
10-Q · filed 2019-05-14
2017-12-31-$5.73M
10-K · filed 2020-06-01
$5.00M
10-K · filed 2018-02-21
2017-09-30$5.00M
10-Q · filed 2017-11-14
2017-06-30$5.00M
10-Q · filed 2017-08-11
2016-12-31$23.20K
10-K · filed 2019-03-05